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CASE REPORT
SUBCUTANEOUS PHAEOHYPHOMYCOSIS BY Exophiala jeanselmei
IN A CARDIAC TRANSPLANT RECIPIENT
Maria do Rosário R. SILVA(1), Orionalda de F.L. FERNANDES(1), Carolina R. COSTA(1), Aiçar CHAUL(2), Luciano F. MORGADO(2),
Luis Fernando FLEURY-JÚNIOR(2) & Maurício B. COSTA(3)
SUMMARY
We report a case of phaeohyphomycosis caused by Exophiala jeanselmei in a cardiac transplant recipient maintained on
immunosuppressive therapy with mycophenolate mofetil tacrolimus and prednisone. The lesion began after trauma on the right
leg that evolved to multiple lesions with nodules and ulcers. Diagnosis was performed by histological examination and culture of
pus from skin lesions. Treatment consisted of itraconazole (200 mg/day) for three months with no improvement and subsequently
with amphotericin B (0.5 mg/Kg per day to a total of 3.8 g intravenously). After four months of treatment, the lesions showed
marked improvement with reduction in the swelling and healing of sinuses and residual scaring.
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INTRODUCTION
Phaeohyphomycosis is a term introduced by AJELLO et al.1 in
1974 and it is used to describe subcutaneous and systemic diseases
caused by a variety of dematiaceous fungi that develop in the form of
darkly pigmented yeast-like cells, hyphae and pseudohyphae in infected
tissue6,10.
Several species of Exophiala, Cladosporium, Alternaria and other
genera of fungi have been recognized as agents of subcutaneous
phaeohyphomycosis4,8,13. The genus Exophiala is widely distributed in
the environment and may cause infections in both immunocompromised
and immunocompetent patients11,12. We report a case of subcutaneous
phaeohyphomycosis caused by Exophiala jeanselmei in a patient with
a cardiac transplant.
CASE REPORT
A 48 year-old man, was admitted to “Hospital de Doenças Tropicais
de Goiânia”, with a nodule on the right lower leg. The lesion began
after trauma on the right leg that evolved to nodules and ulcers (Fig.
1). He had undergone cardiac transplantation eight months before
immunosuppressive therapy included mycophenolate mofetil (3 mg/
day), tacrolimus (5 mg/day) and prednisone (20 mg/day).
Direct examination of the pus from lesion revealed branched pale-
brown hyphae and rounded thick-walled vesicles. Histopathological
examination of tissue sections of a skin biopsy from the lesion showed
mild hyperplasia of the epidermis and supurative granulomatous
inflammation in dermis with budding yeasts and dematiaceous hyphae
(Fig. 2a). Cultures obtained on Sabouraud dextrose agar, produced dark,
moist, olive to black yeast-like colony (Fig. 2b). Microscopically, the
long mycelium, thick-walled septate conidiophores with a ball of
conidia (annelophores) at the tip were visualized (Fig. 2c).
Fig. 1 - Suppurating lesion aspect of right leg with nodules discharging sinuses and ulcers.
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The patient received oral itraconazole (Sporanox), 200 mg daily for
three months, but no improvement was noted. Antifungal susceptibility
testing of the isolate was accomplished by Etest method. Minimal Inhibitory
Concentration (MIC) were 1 µg/mL for amphotericin B (Fungizone,
Squibb, US) and 64 µg/mL for itraconazole. Antifungal treatment with
amphotericin B was started. The dose regimen was 0.5 mg/Kg per day
(alternate days) to a total of 3.8 g intravenously. After four months of
treatment, the lesion showed marked improvement with reduction in the
swelling and closure of sinuses and residual scaring of the tissue.
DISCUSSION
Dematiaceous fungi can produce three different types of infection,
i.e. phaeohyphomycosis, chromoblastomycosis and mycetoma. Unlike
chromoblastomycosis or mycetoma, there are no muriform cells nor
grains in phaeohyphomycosis3,10. Phaeohyphomycosis is a mycosis that
usually presents as single cyst or abscess on exposed area. This infection
is most common in patients with underlying problems and has been
reported after trauma to the skin9. In 54 cases of dematiaceous infections
caused by Exophophiala jeanselmei, underlying diseases were identified
in 23 cases7. The present patient showed multiple nodules and ulcers
on the right leg and a history of local trauma months before the
appearance of the lesion. This patient had undergone cardiac
transplantation and its immunosuppressive regimen included
mycophenolate mofetil, tacrolimus and prednisone, suggesting that
the main reason for this disease in this case was the immunodeficiency.
Diagnosis and identification were made by direct examination with
KOH, histopathological examination of tissue specimens and culture.
Dematiaceous hyphae were seen in our patient specimens. These
characteristics are essential to confirm phaeohyphomycosis.
Isolates of E. jeanselmei grow up as a yeast-like colony, later on
changing to a mould5. In the present case, cultures produced dark, a
moist, olive to black yeast like colony that did not change after two
months of incubation.
No improvement was observed with the administration of oral
itraconazole, however marked reduction in the swelling and closure of
sinuses was obtained after treatment with amphotericin B. This drug
was used because susceptibility test showed high sensibility to this
drug (MIC = 1 µg/mL). Both antifungal agents, either alone or in
combination, have been reported with variable cure rates2.
RESUMO
Feohifomicose subcutânea por Exophiala jeanselmei em um
transplantado cardíaco
Este trabalho relata um caso de feohifomicose subcutânea causado
por Exophiala jeanselmei em um paciente que havia recebido
transplante de coração e mantinha terapia com micofenolato mofetil,
tracolimus e prednisone. As lesões tiveram início após trauma na perna
inferior direita que evoluíram produzindo múltiplos nódulos e úlceras.
Diagnóstico foi realizado através de avaliação histológica e de
características macroscópicas e microscópicas da cultura das lesões
da pele. O paciente fez uso de itraconazol em concentração de 200
mg/dia durante três meses, não se observando no entanto, melhora das
lesões. Após este período, o paciente foi tratado com anfotericina B a
uma concentração de 0,5 mg/Kg/dia totalizando 3,8 g. Após quatro
meses de tratamento as lesões mostraram melhora evidente, verificando-
se fechamento das fístulas e cicatrização das lesões.
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